The crucial question with respect to nuclear medicine training requirements, is what we are aiming for: Do we aim for a "driving license", allowing to drive safely in standard conditions, or is it our ambition to train "race car or Formula 1 drivers", experts that know every part of a car, competent to get the maximum out of it in different terrain and weather conditions and to provide engineers the necessary feedback on every detail for further improvement of the car's performance?
When it comes to nuclear medicine training, both options allow to safely and adequately perform diagnostic and (depending on the "license") therapeutic nuclear medicine procedures in clinical routine. However, only the last, "race car or Formula 1 driver" option ensures that the next generation nuclear medicine physicians will have the necessary skills and competence for shaping the best conditions for the further development of molecular imaging and radionuclide therapy.
Nuclear medicine in Europe has never been in a better shape than today. This is no coincidence, but the result of nuclear medicine being an independent specialty with a 4-to (mostly) 5-year dedicated training program in most European countries. The advantage of such a dedicated training programme is that it covers the pathophysiology and biology of diseases, therapy related radiobiology and dosimetry, integration of functional and molecular imaging in the clinical context and patient management. This clinical and translational approach has been the cornerstone of nuclear medicine since its foundation +/-50 years ago as a joint initiative of internal medicine physicians, physiologists and clinical biologists. This "genetic" link between "molecule and man" providing an insight in the potential of radiopharmaceuticals as well as in the clinical need in patient management, is undoubtedly the key to success, resulting in the recent major advances in molecular imaging and theranostics, opening the door for patienttailored image guided therapy. Due to the many differences between EU Member States with respect to national laws on professional activity (e.g. the use of unsealed radioactive sources is in most EU countries restricted to nuclear medicine physicians, while in other countries its use is authorised for other specialties; a double specialisation is allowed in one EU country and prohibited in another, …), there is a wide diversity of nuclear medicine training programs across Europe, resulting in significant differences in competencies between nuclear medicine physicians, particularly in the field of hybrid / cross-sectional imaging.
In most EU countries, a dedicated nuclear medicine training programme is applied, often consisting of 1-2 years of training in internal medicine and integrating education and training in hybrid imaging in the nuclear medicine curriculum, with or without a dedicated training in anatomic cross-sectional imaging in radiology. Some countries changed their nuclear medicine curriculum recently. In the Netherlands, a combined 5-year residency curriculum for radiology and nuclear medicine 4 has been implemented, with 8 differentiations or subspecialties including one "nuclear medicine and molecular radiology" subspecialty, consisting of 20-month nuclear medicine training. Whether this new training program will allow automatic mutual recognition of qualifications of future Dutch "nuclear radiologists" as a nuclear medicine physician in other EU-countries and vice-versa is still an open question. The same applies for the short and long term effects on the development of nuclear medicine related research at a national level.
Given the wide diversity of national nuclear medicine training programs across Europe and the changes in educational needs of the nuclear medicine community, the EANM decided to review and modernise its educational system by founding in 2016 the European School of Multimodality Imaging & Therapy (ESMIT) 5 as response to the rising demand for education and training in multimodality imaging and the fast-evolving field of theranostics. ESMIT is structured in 3 levels. Level 1, the entry level, is a 100% electronic learning platform covering basic topics. All eLearning contents can be viewed for free and build the basis of knowledge preparing all users appropriately for the upcoming levels. Level 2, the intermediate level, goes to the heart of evidence based teaching, focussing on clinical practice by providing a mixture of theoretical and practical, interactive 3-day courses in academic centres all over Europe. In level 3, the advanced level, knowledge is deepened and expanded for individuals developing subspecialty areas of interest. These high-end courses are held in the EANM Learning Center in Vienna. Currently, EANM/ESMIT and UEMS/EBNM (European Board of Nuclear Medicine) are working closely together to provide certification for each ESMIT-level by next year.
In conclusion, the translational and clinical roots of nuclear medicine are the strength of the specialty and the driving force behind the fast-emerging field of diagnostic and therapeutic applications with radiopharmaceuticals, catalysed by the introduction of hybrid imaging. In Europe, these clinical and translational genes of the specialty are still dominant and expressed in the nuclear medicine training program in most European countries, consistent with the Nuclear Medicine Syllabus of the UEMS and providing the current and future nuclear medicine trainees the necessary dedicated background for contributing to the further development of nuclear medicine throughout Europe. Recent technological and radiopharmaceutical developments contributed to tremendous progress in the field of nuclear medicine, creating the need for changes in the nuclear medicine training program. ESMIT is EANM's answer to this need for education in cross-sectional and multimodality imaging as well as in the fast-emerging new diagnostic and therapeutic nuclear medicine procedures by providing a 3-level (basic up-to expert level) education structure; a certification for each level is under development in collaboration with UEMS/EBNM.
